Health Sciences Acquisitions Co. 2 (HSAQ) Competitors $5.28 +0.11 (+2.13%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsTrends HSAQ vs. UTMD, SKIN, OBIO, INFU, PROF, SGHT, ARAY, BWAY, DRTS, and NVROShould you be buying Health Sciences Acquisitions Co. 2 stock or one of its competitors? The main competitors of Health Sciences Acquisitions Co. 2 include Utah Medical Products (UTMD), Beauty Health (SKIN), Orchestra BioMed (OBIO), InfuSystem (INFU), Profound Medical (PROF), Sight Sciences (SGHT), Accuray (ARAY), BrainsWay (BWAY), Alpha Tau Medical (DRTS), and Nevro (NVRO). These companies are all part of the "surgical & medical instruments" industry. Health Sciences Acquisitions Co. 2 vs. Utah Medical Products Beauty Health Orchestra BioMed InfuSystem Profound Medical Sight Sciences Accuray BrainsWay Alpha Tau Medical Nevro Utah Medical Products (NASDAQ:UTMD) and Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, community ranking, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk. Which has more risk and volatility, UTMD or HSAQ? Utah Medical Products has a beta of 0.08, meaning that its share price is 92% less volatile than the S&P 500. Comparatively, Health Sciences Acquisitions Co. 2 has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Does the media refer more to UTMD or HSAQ? In the previous week, Utah Medical Products had 1 more articles in the media than Health Sciences Acquisitions Co. 2. MarketBeat recorded 1 mentions for Utah Medical Products and 0 mentions for Health Sciences Acquisitions Co. 2. Utah Medical Products' average media sentiment score of 1.54 beat Health Sciences Acquisitions Co. 2's score of 0.45 indicating that Utah Medical Products is being referred to more favorably in the media. Company Overall Sentiment Utah Medical Products Very Positive Health Sciences Acquisitions Co. 2 Neutral Does the MarketBeat Community believe in UTMD or HSAQ? Utah Medical Products received 154 more outperform votes than Health Sciences Acquisitions Co. 2 when rated by MarketBeat users. CompanyUnderperformOutperformUtah Medical ProductsOutperform Votes15461.60% Underperform Votes9638.40% Health Sciences Acquisitions Co. 2N/AN/A Do insiders & institutionals believe in UTMD or HSAQ? 69.6% of Utah Medical Products shares are held by institutional investors. Comparatively, 89.7% of Health Sciences Acquisitions Co. 2 shares are held by institutional investors. 6.6% of Utah Medical Products shares are held by company insiders. Comparatively, 21.9% of Health Sciences Acquisitions Co. 2 shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has preferable earnings & valuation, UTMD or HSAQ? Utah Medical Products has higher revenue and earnings than Health Sciences Acquisitions Co. 2. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUtah Medical Products$50.22M4.33$16.64M$4.2715.03Health Sciences Acquisitions Co. 2N/AN/A-$380KN/AN/A Is UTMD or HSAQ more profitable? Utah Medical Products has a net margin of 34.62% compared to Health Sciences Acquisitions Co. 2's net margin of 0.00%. Utah Medical Products' return on equity of 12.10% beat Health Sciences Acquisitions Co. 2's return on equity.Company Net Margins Return on Equity Return on Assets Utah Medical Products34.62% 12.10% 11.50% Health Sciences Acquisitions Co. 2 N/A N/A -2.38% SummaryUtah Medical Products beats Health Sciences Acquisitions Co. 2 on 8 of the 11 factors compared between the two stocks. Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Get Health Sciences Acquisitions Co. 2 News Delivered to You Automatically Sign up to receive the latest news and ratings for HSAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSAQ vs. The Competition Export to ExcelMetricHealth Sciences Acquisitions Co. 2Surgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$59.20M$4.47B$5.06B$8.89BDividend YieldN/A36.79%4.97%4.06%P/E RatioN/A12.8689.0213.30Price / SalesN/A45.351,207.2881.01Price / CashN/A52.2339.1736.03Price / Book-8.525.676.085.74Net Income-$380,000.00$13.76M$119.07M$225.93M7 Day Performance-13.01%-1.08%-1.84%-1.32%1 Month Performance-1.31%0.58%-3.65%0.60%1 Year Performance-21.66%50.91%31.62%26.23% Health Sciences Acquisitions Co. 2 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSAQHealth Sciences Acquisitions Co. 2N/A$5.28+2.1%N/A-23.3%$59.20MN/A0.004UTMDUtah Medical Products3.4454 of 5 stars$64.18-0.8%N/A-23.5%$219.40M$50.22M15.03180Positive NewsSKINBeauty Health2.6897 of 5 stars$1.49-7.5%$2.55+71.1%-36.3%$200.29M$398M0.001,030Analyst RevisionPositive NewsOBIOOrchestra BioMed2.6492 of 5 stars$5.28+2.1%$15.75+198.3%-21.7%$196.53M$2.76M0.0056Analyst RevisionINFUInfuSystem1.6869 of 5 stars$9.03-0.8%$13.00+44.0%N/A$193.50M$125.79M151.67499PROFProfound Medical2.4531 of 5 stars$7.69-1.8%$13.75+78.8%-31.2%$193.10M$7.20M0.00150Positive NewsSGHTSight Sciences2.5151 of 5 stars$3.73-1.1%$5.50+47.5%+63.6%$191.35M$81.06M0.00210ARAYAccuray4.6437 of 5 stars$1.83-0.5%$9.00+391.8%-32.5%$185.04M$444.20M-10.76987Analyst RevisionBWAYBrainsWay4.1911 of 5 stars$9.83+1.7%$13.17+33.9%+103.9%$163.96M$31.78M96.71120Gap UpDRTSAlpha Tau Medical2.4021 of 5 stars$2.30flat$8.00+248.6%-20.7%$160.24MN/A0.0080NVRONevro2.8885 of 5 stars$4.23-0.2%$9.10+115.1%-74.5%$158.88M$425.17M0.001,215Analyst UpgradeGap Down Related Companies and Tools Related Companies Utah Medical Products Competitors Beauty Health Competitors Orchestra BioMed Competitors InfuSystem Competitors Profound Medical Competitors Sight Sciences Competitors Accuray Competitors BrainsWay Competitors Alpha Tau Medical Competitors Nevro Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HSAQ) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Sciences Acquisitions Co. 2 Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Sciences Acquisitions Co. 2 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
